Showing results (641-650 of 1,353) with videos related to
Sort By:
Pageof 136
Disaster Medicine and Public Health Preparedness|November 7, 2018
Environmental Heat Exposure and Heat-Related Symptoms in United States Coast Guard Deepwater Horizon Disaster RespondersElizabeth A Erickson, Lawrence S Engel, Kate Christenbury, et al.Ophthalmology and Eye Diseases|December 17, 2016
The Monocular Duke of UrbinoStephen G Schwartz, Christopher T Leffler, Pamela S Chavis, et al.Journal of Cancer Research and Clinical Oncology|March 6, 2003
19-nor-1alpha,25-dihydroxyvitamin D(2) (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell linesIstván Molnár, Timothy Kute, Mark C Willingham, et al.American Journal of Ophthalmology|June 15, 2010
Fovea-sparing retinal detachments: time to surgery and visual outcomesCharles C Wykoff, William E Smiddy, Tahira Mathen, et al.Clinical Ophthalmology (Auckland, N.Z.)|March 16, 2012
Insight into 144 patients with ocular vascular events during VEGF antagonist injectionsAhmad M Mansour, Maha Shahin, Peter K Kofoed, et al.Depression and Anxiety|November 11, 2021
Transactional patterns of depressive symptoms between mothers and adolescents: The role of emotion regulationJulia W Felton, Karen T G Schwartz, Lauren E Oddo, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Platelet 3H-imipramine binding: a state-dependent marker in depressionB Suranyi-Cadotte, R Quirion, P McQuade, et al.American Heart Journal|June 25, 2004
Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trialGregory G Schwartz, Michael A Bolognese, Benoit P Tremblay, et al.Annals of Neurology|April 1, 1979
Atrial myxoma with intellectual decline and cerebral growths on CT scanR A Frank, P R Shalen, D G Harvey, et al.Cancer|February 15, 1994
Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapyI Tepler, G Schwartz, K Parker, et al.Pageof 136